Baseline | Post- treatment (10 weeks) | Follow-up (12 months) | |||||
---|---|---|---|---|---|---|---|
Variable | Therapy | M | (SD) | M | (SD) | M | (SD) |
BPD symptoms (BSL-23) | Support | 52.25 | (18.71) | 42.63 | (24.86) | 37.13 | (20.53) |
Iconic | 51.40 | (22.03) | 40.10 | (24.63) | 28.06 | (21.82) | |
Cohen’s d | 0.13a | 0.33b | |||||
Suicide Ideation (C-SSRS) | Support | 4.00 | (0.97) | 2.68 | (1.66) | 1.33 | (1.75) |
Iconic | 3.55 | (1.46) | 2.00 | (2.00) | 1.00 | (1.45) | |
Cohen’s d | 0.17a | 0.04b | |||||
Maladjustment to daily life (IG) | Support | 23.30 | (5.07) | 19.21 | (9.44) | 16.27 | (8.68) |
Iconic | 20.60 | (6.62) | 15.10 | (7.70) | 9.82 | (6.69) | |
Cohen’s d | 0.18a | 0.39b | |||||
Psychopharmacology consumption. N (%) | Support | 14 | 70.0% | 10 | 52.6% | 8 | 53.3% |
Iconic | 14 | 70.0% | 11 | 55.0% | 5 | 29.4% |